Angiotensin-converting enzyme gene I/D polymorphism and renal disease

被引:28
作者
Navis, G
van der Kleij, FGH
de Zeeuw, D
de Jong, PE
机构
[1] Univ Groningen Hosp, Dept Internal Med, Inst Drug Explorat, Div Nephrol,Dept Clin Pharmcol, NL-9700 RB Groningen, Netherlands
[2] Univ Groningen, NL-9700 RB Groningen, Netherlands
来源
JOURNAL OF MOLECULAR MEDICINE-JMM | 1999年 / 77卷 / 11期
关键词
ACE I/D polymorphism; genetic polymorphism; renal disease; ACE inhibitors; progressive renal disease;
D O I
10.1007/s001099900063
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
In recent years a vast amount of data has been published on the association between the insertion/deletion (VD) polymorphism of the gene coding for angiotensin-converting enzyme and renal disease. It has be come clear that the polymorphism does not affect the prevalence of renal disease. However, data on the association with progression of renal disease and therapy response are still contradictory. Moreover, sufficient data on the physiological significance of this polymorphism are still lacking. This contribution provides an overview of the available studies and the potential pitfalls in interpreting the data. We also discuss the putative mechanisms for the association between the DD genotype and progression of renal disease and suggest directions for the future that might be employed to further clarify the role in renal pathophysiology.
引用
收藏
页码:781 / 791
页数:11
相关论文
共 124 条
[71]   GENOTYPIC INFLUENCE ON PLASMA DIPEPTIDYL CARBOXYPEPTIDASE-1 ACTIVITY IN HYPERTENSIVES [J].
MORRIS, BJ ;
MONAGHAN, JC ;
PERICH, R ;
STOKES, GS ;
JACKSON, B ;
SCHRADER, AP .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1994, 21 (04) :343-346
[72]   MODERATE SODIUM RESTRICTION IN HYPERTENSIVE SUBJECTS - RENAL EFFECTS OF ACE-INHIBITION [J].
NAVIS, G ;
DEJONG, PE ;
DONKER, AJM ;
VANDERHEM, GK ;
DEZEEUW, D .
KIDNEY INTERNATIONAL, 1987, 31 (03) :815-819
[73]   ACE-inhibitors: Panacea for progressive renal disease? [J].
Navis, G ;
deZeeuw, D ;
deJong, PE .
LANCET, 1997, 349 (9069) :1852-1853
[74]   ANGIOTENSIN-CONVERTING ENZYME GENE POLYMORPHISM IN HEMODIALYSIS-PATIENTS [J].
NOMURA, H ;
KONI, I ;
MICHISHITA, Y ;
MORISE, T ;
TAKEDA, R .
LANCET, 1994, 343 (8895) :482-483
[75]   Recurrent immunoglobulin A nephropathy after renal transplantation [J].
Ohmacht, C ;
Kliem, V ;
Burg, M ;
Nashan, B ;
Schlitt, HJ ;
Brunkhorst, R ;
Koch, KM ;
Floege, J .
TRANSPLANTATION, 1997, 64 (10) :1493-1496
[76]  
Parving HH, 1996, BRIT MED J, V313, P591
[77]   PREVALENCE AND CAUSES OF ALBUMINURIA IN NON-INSULIN-DEPENDENT DIABETIC-PATIENTS [J].
PARVING, HH ;
GALL, MA ;
SKOTT, P ;
JORGENSEN, HE ;
LOKKEGAARD, H ;
JORGENSEN, F ;
NIELSEN, B ;
LARSEN, S .
KIDNEY INTERNATIONAL, 1992, 41 (04) :758-762
[78]   Association of angiotensinogen gene T235 variant with progression of immunoglobin A nephropathy in Caucasian patients [J].
Pei, Y ;
Scholey, J ;
Thai, K ;
Suzuki, M ;
Cattran, D .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (04) :814-820
[79]   Effect of angiotensin-converting enzyme (ACE) gene polymorphism on progression of renal disease and the influence of ACE inhibition in IDDM patients - Findings from the EUCLID randomized controlled trial [J].
Penno, G ;
Chaturvedi, N ;
Talmud, PJ ;
Cotroneo, P ;
Manto, A ;
Nannipieri, M ;
Luong, LA ;
Fuller, JH .
DIABETES, 1998, 47 (09) :1507-1511
[80]  
Perrichot R, 1996, J AM SOC NEPHROL, V7, pA2665